In vivo drug target discovery: identifying the best targets from the genome.

A vast number of genes of unknown function threaten to clog drug discovery pipelines. To develop therapeutic products from novel genomic targets, it will be necessary to correlate biology with gene sequence information. Industrialized mouse reverse genetics is being used to determine gene function in the context of mammalian physiology and to identify the best targets for drug development.

[1]  D. Yamashita,et al.  Cathepsin K and the design of inhibitors of cathepsin K. , 2000, Current pharmaceutical design.

[2]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[3]  T. Taniguchi,et al.  The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice. , 2001, Cytokine & growth factor reviews.

[4]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Harris.  Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies. , 2001, Drug discovery today.

[6]  S. Wattler,et al.  Construction of Gene Targeting Vectors from λKOS Genomic Libraries , 1999 .

[7]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[8]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[9]  H. Scrable,et al.  The lac operator-repressor system is functional in the mouse. , 2001, Genes & development.

[10]  I. Kola,et al.  Osteopetrosis and osteoporosis: two sides of the same coin. , 1999, Human molecular genetics.

[11]  D. Szymkowski.  Too many targets, not enough target validation. , 2001, Drug discovery today.

[12]  Mario R. Capecchi,et al.  Generating mice with targeted mutations , 2001, Nature Medicine.

[13]  R. Cone,et al.  Genetic models of obesity and energy balance in the mouse. , 2000, Annual review of genetics.

[14]  M. Linton,et al.  Mouse models of hyperlipidemia and atherosclerosis. , 2001, Frontiers in bioscience : a journal and virtual library.

[15]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[16]  L. Donehower,et al.  Murine tumor suppressor models. , 1998, Mutation research.

[17]  Christophe Person,et al.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells , 1998, Nature.

[18]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[19]  B. Beck.  KO's and organisation of peptidergic feeding behavior mechanisms , 2001, Neuroscience & Biobehavioral Reviews.